Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rigel Pharmaceuticals (NQ: RIGL )

2.470 USD -0.100 (-3.89%)
Official Closing Price Updated: 6:47 PM EDT, Oct 21, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,558,331
Open 2.550
Bid (Size) 2.460 (1)
Ask (Size) 2.490 (31)
Prev. Close 2.570
Today's Range 2.430 - 2.570
52wk Range 1.230 - 5.240
Shares Outstanding 163,580,297
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Rigel Announces First Patients Enrolled in NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
Trial being conducted at NIH Clinical Center in Bethesda, Maryland and Inova Fairfax Hospital in Virginia 
From PR Newswire
Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the start of a multicenter, Phase 2 trial to evaluate the safety of fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, for the... 
From PR Newswire

Performance

YTD
+22.28%
+22.28%
1 Month
+3.35%
+3.35%
3 Month
-14.83%
-14.83%
6 Month
+62.50%
+62.50%
1 Year
+47.02%
+47.02%

More News

Read More
Rigel to Present at Two Upcoming Investor Conferences
From PR Newswire
Rigel to Participate in Citi's 15th Annual BioPharma Virtual Conference
From PR Newswire
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From PR Newswire
First Week of June 2021 Options Trading For Rigel Pharmaceuticals (RIGL)
Tags Stocks
From Market News Video
Rigel Reports Second Quarter 2020 Financial Results, Provides Business Update, and Overviews COVID-19 Program
From PR Newswire
Thinking about buying stock in Just Energy, Extreme Networks, Aurora Cannabis, AcelRx Pharmaceuticals, or Rigel Pharmaceuticals?
From PR Newswire
Either Analysts Got The Components Wrong or Russell 2000 Headed 22% Higher
Tags ETFs
From ETF Channel
Return On Capital Employed Overview: Rigel Pharmaceuticals
Tags RIGL General Health Care
From Benzinga
Coronavirus update: Global cases near 30 million; Trump contradicts CDC head on vaccine timetable and again derides face masks
Tags WMT DAL SPX
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.